Death’s legal definition must be responsive to advances in technology, and it must delineate between life and death. Knowing where to draw the line is difficult.
AMA J Ethics. 2020;22(12):E1055-1061. doi:
10.1001/amajethics.2020.1055.
Dr Ariane Lewis discusses how we can navigate uncertainty and ambiguity about brain death by understanding clinical criteria for brain death determination and how our approaches to death are culturally and socially situated.
Countering the prevailing thought that more medical testing and treatment is always better can be achieved by creating a forum for open discussion of costs and value to prevent patient harm from overuse.
AMA J Ethics. 2015;17(11):1079-1081. doi:
10.1001/journalofethics.2015.17.11.mnar1-1511.
Carly P. Smith, PhD and Daniel R. George, PhD, MSc
Invisibility of racial inequity and gender inclusion in clinical research means key features of disease etiology and symptom presentation are unaccounted for.
AMA J Ethics. 2021;23(7):E563-568. doi:
10.1001/amajethics.2021.563.